Literature DB >> 26911307

Emerging nanomedicine applications and manufacturing: progress and challenges.

Felicity Sartain1, Francesca Greco2, Kathryn Hill3, Steve Rannard4, Andrew Owen5.   

Abstract

APS 6th International PharmSci Conference 2015 7-9 September 2015 East Midlands Conference Centre, University of Nottingham, Nottingham, UK As part of the 6th APS International PharmSci Conference, a nanomedicine session was organised to address challenges and share experiences in this field. Topics ranged from the reporting on latest results and advances in the development of targeted therapeutics to the needs that the community faces in how to progress these exciting proof of concept results into products. Here we provide an overview of the discussion and highlight some of the initiatives that have recently been established to support the translation of nanomedicines into the clinic.

Entities:  

Mesh:

Year:  2016        PMID: 26911307     DOI: 10.2217/nnm.16.17

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  2 in total

Review 1.  Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration-Approved Nanodrug Delivery Platforms.

Authors:  Ibra S Fancher; Israel Rubinstein; Irena Levitan
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 2.  Nanoparticle-based drug delivery systems: What can they really do in vivo?

Authors:  Yi-Feng Wang; Lu Liu; Xue Xue; Xing-Jie Liang
Journal:  F1000Res       Date:  2017-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.